Company Filing History:
Years Active: 2017
Title: Innovations by Rahul Shripad Nandurdikar
Introduction
Rahul Shripad Nandurdikar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate calcium release-activated calcium (CRAC) channels. His work is essential for advancing medical treatments for various diseases and disorders.
Latest Patents
Nandurdikar holds a patent for "Substituted heterocyclic compounds as CRAC modulators." This invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts. The patent details the use of these compounds in medicine for treating diseases associated with the modulation of CRAC channels. The invention also encompasses pharmaceutical compositions containing such compounds, which are crucial for addressing disorders linked to CRAC channel modulation.
Career Highlights
Nandurdikar is currently employed at Lupin, Inc., a prominent pharmaceutical company. His role involves research and development, focusing on innovative solutions in the medical field. His expertise and dedication have contributed to the advancement of pharmaceutical sciences.
Collaborations
Throughout his career, Nandurdikar has collaborated with talented professionals, including Nageswara Rao Irlapati and Nilesh Raghunath Khedkar. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Rahul Shripad Nandurdikar's contributions to the field of pharmaceuticals through his innovative patents highlight his importance as an inventor. His work continues to impact the medical community positively, paving the way for new treatments and therapies.